|
NCT00663624
|
|
Management of Hyperglycemia in the ER: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care
|
Phase 4
|
Withdrawn
|
|
NCT01966978
|
2014-11-01 |
The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
|
Phase 4
|
Recruiting
|
|
NCT02269735
|
2014-11-01 |
A Two Part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Part II) (MK-2640-001)
|
Phase 1
|
Recruiting
|
|
NCT02276859
|
2014-10-01 |
Normal Versus Dual Wave Insulin Bolus for High-protein Food
|
Phase 4
|
Not Yet Recruiting
|
|
NCT02158182
|
2014-07-01 |
Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding
|
Phase 4
|
Recruiting
|
|
NCT02101229
|
2014-05-01 |
Validation of the Artificial Pancreas Diabeloop Algorithm in the Hospital
|
Phase 2/Phase 3
|
Recruiting
|
|
NCT02131246
|
2014-05-01 |
A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT02100475
|
2014-04-01 |
A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification
|
Phase 3
|
Active, Not Recruiting
|
|
NCT02089451
|
2014-03-01 |
A Trial Comparing the Pharmacokinetic Properties of Faster-acting Insulin Aspart (FIAsp) After Different Injection Regions and Routes of Administration in Healthy Subjects
|
Phase 1
|
Completed
|
|
NCT02043587
|
2014-01-01 |
Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma
|
Phase 2
|
Recruiting
|
|
NCT02033239
|
2014-01-01 |
A Trial Investigating the Pharmacodynamic Response of Faster Acting Insulin Aspart in Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT02035371
|
2014-01-01 |
A Trial Investigating the Pharmacokinetic Properties of FIAsp in Children, Adolescents and Adults With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT02034513
|
2014-01-01 |
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes
|
Phase 3
|
Active, Not Recruiting
|
|
NCT01722578
|
2013-12-01 |
L-ornithine L-aspartate in Overt Hepatic Encephalopathy
|
Phase 4
|
Recruiting
|
|
NCT01992588
|
2013-11-01 |
A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp When Administered as a Bolus in a Continuous Subcutaneous Infusion Regimen in Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT01999322
|
2013-11-01 |
A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes
|
Phase 3
|
Completed
|
|
NCT02003677
|
2013-11-01 |
A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Geriatric and Younger Adult Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT01835431
|
2013-10-01 |
A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus
|
Phase 3
|
Completed
|
|
NCT01819129
|
2013-09-01 |
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT01850615
|
2013-09-01 |
Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT01924637
|
2013-08-01 |
A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT01831765
|
2013-08-01 |
Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes
|
Phase 3
|
Active, Not Recruiting
|
|
NCT01934712
|
2013-08-01 |
A Trial Investigating the Pharmacokinetic Properties of FIAsp in Japanese Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT01892020
|
2013-06-01 |
Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus
|
Phase 4
|
Completed
|
|
NCT01814137
|
2013-03-01 |
A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily
|
Phase 3
|
Completed
|
|
NCT01848990
|
2013-03-01 |
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)
|
Phase 4
|
Active, Not Recruiting
|
|
NCT01713530
|
2013-02-01 |
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
|
Phase 3
|
Completed
|
|
NCT01773798
|
2013-01-01 |
A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT01792830
|
2012-10-01 |
Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft(CABG) Patients
|
Phase 3
|
Active, Not Recruiting
|
|
NCT01682902
|
2012-09-01 |
A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT01648218
|
2012-08-01 |
Insulin Therapy for Post-transplant Glucocorticoid Induced Hyperglycemia
|
Phase 4
|
Recruiting
|
|
NCT01680341
|
2012-08-01 |
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
|
Phase 3
|
Completed
|
|
NCT01561378
|
2012-08-01 |
Cardiac Surgery Neuroprotection Study in Elders
|
Phase 2
|
Completed
|
|
NCT01618214
|
2012-06-01 |
Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT01519674
|
2012-06-01 |
Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin
|
Phase 4
|
Completed
|
|
NCT01618188
|
2012-06-01 |
A Trial Investigating the Pharmacodynamic Properties of NN1218 in Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT01510093
|
2012-05-01 |
Diurnal Variation of Exogenous Peptides (Endogenous Insulin Jurgita II)
|
Phase 2
|
Completed
|
|
NCT01589653
|
2012-05-01 |
Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients
|
Phase 4
|
Active, Not Recruiting
|
|
NCT01590836
|
2012-04-01 |
A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT01540812
|
2012-02-01 |
Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS
|
Phase 4
|
Recruiting
|
|
NCT01513590
|
2012-01-01 |
A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT01513473
|
2012-01-01 |
A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus
|
Phase 3
|
Completed
|
|
NCT01440829
|
2011-12-01 |
The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS
|
Phase 2/Phase 3
|
Completed
|
|
NCT01526733
|
2011-12-01 |
Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase
|
Phase 4
|
Completed
|
|
NCT00700362
|
2011-12-01 |
Insulin Infusion and Infectious Diabetic Foot Ulcers (IIIFU)
|
Phase 4
|
Withdrawn
|
|
NCT01474538
|
2011-12-01 |
Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy
|
Phase 3
|
Completed
|
|
NCT01486966
|
2011-11-01 |
Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes
|
Phase 4
|
Terminated
|
|
NCT01469143
|
2011-11-01 |
A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT01455142
|
2011-10-01 |
A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT01417897
|
2011-09-01 |
Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot Study
|
Phase 4
|
Active, Not Recruiting
|
|
NCT01388361
|
2011-09-01 |
Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin
|
Phase 3
|
Completed
|
|
NCT01427920
|
2011-09-01 |
Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT01678235
|
2011-09-01 |
Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus
|
Phase 4
|
Completed
|
|
NCT01445951
|
2011-09-01 |
Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period
|
Phase 3
|
Completed
|
|
NCT01365507
|
2011-06-01 |
Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens
|
Phase 3
|
Completed
|
|
NCT01407289
|
2011-06-01 |
A Trial to Investigate Efficacy and Usability of Published Best Practice to Control Glycaemia
|
Phase 4
|
Completed
|
|
NCT01333514
|
2011-04-01 |
Carbohydrate Consumption as a Factor in Aspart Dosing
|
Phase 4
|
Completed
|
|
NCT01399346
|
2011-04-01 |
Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT01215435
|
2011-03-01 |
Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs Alone
|
Phase 4
|
Completed
|
|
NCT01242826
|
2011-02-01 |
Investigation of the Pharmacokinetic Properties of Biphasic Insulin Aspart 50 in Healthy Chinese Subjects
|
Phase 1
|
Completed
|
|
NCT01296438
|
2011-02-01 |
A Trial Investigating the Pharmacokinetic Properties of NN1218 in Subjects With Diabetes Mellitus, Type 1
|
Phase 1
|
Completed
|
|
NCT01275131
|
2011-01-01 |
Randomized, Double-blind, Crossover, Pharmacokinetic (PK) and Glucodynamic (GD) Study of Continuous Subcutaneous Insulin Infusion (CSII) in Participants With Type 1 Diabetes Mellitus (T1DM)
|
Phase 1
|
Completed
|
|
NCT01272193
|
2011-01-01 |
Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjets With Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT01501149
|
2011-01-01 |
Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ
|
Phase 4
|
Recruiting
|
|
NCT01278160
|
2011-01-01 |
Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756
|
Phase 4
|
Completed
|
|
NCT01269606
|
2011-01-01 |
Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT01134107
|
2010-11-01 |
Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use
|
Phase 3
|
Completed
|
|
NCT01165684
|
2010-10-01 |
Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen
|
Phase 4
|
Completed
|
|
NCT01196104
|
2010-09-01 |
Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler
|
Phase 3
|
Terminated
|
|
NCT01190956
|
2010-09-01 |
Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes: An Extension Trial to NN1250-3585
|
Phase 3
|
Completed
|
|
NCT01212913
|
2010-08-01 |
Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM)
|
Phase 4
|
Completed
|
|
NCT01194245
|
2010-08-01 |
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
|
Phase 2
|
Completed
|
|
NCT01194258
|
2010-08-01 |
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus
|
Phase 2
|
Completed
|
|
NCT01174303
|
2010-08-01 |
A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT01173926
|
2010-07-01 |
Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT01293396
|
2010-06-01 |
Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids
|
Phase 4
|
Completed
|
|
NCT01138488
|
2010-06-01 |
A Trial Investigating the Total Exposure of NN5401 in Children, Adolescents and Adult Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT01101867
|
2010-06-01 |
Prandial Insulin Dosing in Hospitalized Patients
|
Phase 4
|
Completed
|
|
NCT01134224
|
2010-05-01 |
A Trial Investigating the Effect of NN5401 in Subjects With Type 2 Diabetes
|
Phase 1
|
Completed
|
|
NCT01125553
|
2010-05-01 |
A Comparison Between Two Formulations of NN5401 in Healthy Subjects
|
Phase 1
|
Completed
|
|
NCT01123980
|
2010-05-01 |
Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin Treatment
|
Phase 4
|
Completed
|
|
NCT01121276
|
2010-04-01 |
A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 Diabetes
|
Phase 1
|
Completed
|
|
NCT01121289
|
2010-04-01 |
A Trial Investigating NN1218 in Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT01109316
|
2010-04-01 |
Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use
|
Phase 3
|
Completed
|
|
NCT01079234
|
2010-03-01 |
Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes
|
Phase 3
|
Completed
|
|
NCT01068652
|
2010-03-01 |
Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs
|
Phase 4
|
Completed
|
|
NCT01074268
|
2010-02-01 |
Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes
|
Phase 3
|
Completed
|
|
NCT01059812
|
2010-02-01 |
A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT01045447
|
2010-01-01 |
Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT01051102
|
2010-01-01 |
Effect of NN5401 in Japanese Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT01828970
|
2010-01-01 |
Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients
|
Phase 4
|
Completed
|
|
NCT01045707
|
2010-01-01 |
Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT00791102
|
2010-01-01 |
Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC)
|
Phase 2/Phase 3
|
Completed
|
|
NCT01079364
|
2010-01-01 |
Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting
|
Phase 4
|
Terminated
|
|
NCT01041755
|
2009-12-01 |
Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.
|
Phase 4
|
Completed
|
|
NCT01009580
|
2009-11-01 |
Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT01028404
|
2009-11-01 |
A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 Diabetes
|
Phase 1
|
Completed
|
|
NCT00992537
|
2009-10-01 |
Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 Diabetics
|
Phase 1
|
Completed
|
|
NCT00993096
|
2009-09-01 |
Investigation of the Response Relationship of NN5401 in Type 1 Diabetics
|
Phase 1
|
Completed
|
|
NCT00972283
|
2009-09-01 |
Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT00979875
|
2009-09-01 |
A Pharmacokinetic and Glucodynamic Study of Subcutaneously Administered Insulin Analogs With rHuPH20 Compared to Insulin Analogs Alone
|
Phase 1
|
Completed
|
|
NCT00982228
|
2009-09-01 |
Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes
|
Phase 3
|
Completed
|
|
NCT00978627
|
2009-08-01 |
Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes
|
Phase 3
|
Completed
|
|
NCT00850161
|
2009-07-01 |
Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin
|
Phase 2
|
Withdrawn
|
|
NCT00965549
|
2009-07-01 |
Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes Patients
|
Phase 4
|
Completed
|
|
NCT00913497
|
2009-06-01 |
The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children
|
Phase 4
|
Completed
|
|
NCT00888732
|
2009-06-01 |
A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, BIAsp70, BIAsp50 and Fast-acting Human Insulin
|
Phase 3
|
Completed
|
|
NCT00933673
|
2009-06-01 |
New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma
|
Phase 2
|
Recruiting
|
|
NCT00906529
|
2009-05-01 |
Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin
|
Phase 4
|
Recruiting
|
|
NCT00942318
|
2009-03-01 |
Efficacy of Continuous Subcutaneous Insulin Infusion Versus Basal-bolus Multiple Daily Injections Regimen in Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT00821795
|
2009-02-01 |
Veterans Inpatient Insulin Study and Transition to Outpatient Therapy
|
Phase 4
|
Completed
|
|
NCT00842361
|
2009-01-01 |
Comparison of NN5401 Versus Biphasic Insulin Aspart 30 on a Twice Daily Regimen in Subjects With Type 2 Diabetes Mellitus
|
Phase 2
|
Completed
|
|
NCT00841087
|
2009-01-01 |
Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 Diabetes
|
Phase 2
|
Completed
|
|
NCT00807092
|
2008-12-01 |
Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT00896831
|
2008-11-01 |
Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy
|
Phase 4
|
Enrolling By Invitation
|
|
NCT00797823
|
2008-11-01 |
Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone
|
Phase 2
|
Completed
|
|
NCT00785811
|
2008-10-01 |
Effect of Chronic Supplementation of L-arginine in the Muscular Performance
|
Phase 4
|
Terminated
|
|
NCT00740142
|
2008-09-01 |
Efficacy of Combined Oral L-Ornithine-L-Aspartate and Lactulose in Patients With Hepatic Encephalopathy
|
Phase 4
|
Recruiting
|
|
NCT01464099
|
2008-06-01 |
Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT01868581
|
2008-05-01 |
Bioequivalence Between Two Explorative Insulin Degludec Formulations and Between Two Explorative IDegAsp Formulations in Healthy Subjects
|
Phase 1
|
Completed
|
|
NCT00591227
|
2008-05-01 |
Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol.
|
Phase 4
|
Completed
|
|
NCT01868568
|
2008-04-01 |
Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT00657943
|
2008-04-01 |
The Copenhagen Insulin and Metformin Therapy Trial
|
Phase 4
|
Completed
|
|
NCT00623194
|
2008-02-01 |
Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689
|
Phase 3
|
Completed
|
|
NCT00627445
|
2008-02-01 |
Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT00614055
|
2008-01-01 |
Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes
|
Phase 2
|
Completed
|
|
NCT00613951
|
2008-01-01 |
Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes
|
Phase 2
|
Completed
|
|
NCT00612040
|
2008-01-01 |
Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes
|
Phase 2
|
Completed
|
|
NCT00607087
|
2008-01-01 |
Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus
|
Phase 4
|
Completed
|
|
NCT01868555
|
2007-12-01 |
Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects
|
Phase 1
|
Completed
|
|
NCT00969592
|
2007-11-01 |
Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy Volunteers
|
Phase 1
|
Completed
|
|
NCT00669864
|
2007-11-01 |
Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin
|
Phase 4
|
Completed
|
|
NCT00537303
|
2007-10-01 |
Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT00537277
|
2007-10-01 |
Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADs
|
Phase 4
|
Completed
|
|
NCT00581867
|
2007-10-01 |
Memory and Insulin in Early Alzheimer's Disease
|
Phase 2
|
Completed
|
|
NCT01159353
|
2007-09-01 |
Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart
|
Phase 1
|
Completed
|
|
NCT00542620
|
2007-09-01 |
Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial
|
Phase 4
|
Completed
|
|
NCT00523042
|
2007-08-01 |
Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma
|
Phase 3
|
Terminated
|
|
NCT00824668
|
2007-08-01 |
Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes
|
Phase 1
|
Completed
|
|
NCT00497536
|
2007-07-01 |
Pharmacokinetics of IAsp Following CSII in Patients With T1DM
|
Phase 4
|
Completed
|
|
NCT00505882
|
2007-07-01 |
Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes
|
Phase 4
|
Withdrawn
|
|
NCT00509925
|
2007-07-01 |
Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes
|
Phase 4
|
Terminated
|
|
NCT00998335
|
2007-06-01 |
Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT00469092
|
2007-05-01 |
Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT00346996
|
2007-05-01 |
Insulin Analogues and Severe Hypoglycaemia
|
Phase 4
|
Completed
|
|
NCT00472953
|
2007-05-01 |
Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3
|
Terminated
|
|
NCT00467649
|
2007-05-01 |
A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT00474045
|
2007-05-01 |
Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes
|
Phase 3
|
Completed
|
|
NCT00473967
|
2007-05-01 |
Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults
|
Phase 1
|
Terminated
|
|
NCT00771693
|
2007-05-01 |
Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With Non-insulin-dependent Diabetes Mellitus (NIDDM)
|
Phase 4
|
Completed
|
|
NCT00476437
|
2007-04-01 |
Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.
|
Phase 3
|
Completed
|
|
NCT00449839
|
2007-04-01 |
Changes of the Infusion Rate in Insulin Pump Treatment
|
Phase 4
|
Completed
|
|
NCT00447382
|
2007-03-01 |
Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes
|
Phase 3
|
Completed
|
|
NCT00825253
|
2007-03-01 |
Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 Diabetes
|
Phase 1
|
Completed
|
|
NCT00435019
|
2007-02-01 |
Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes
|
Phase 3
|
Completed
|
|
NCT00434954
|
2007-02-01 |
Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT00590226
|
2006-12-01 |
Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes
|
Phase 4
|
Completed
|
|
NCT01865331
|
2006-12-01 |
Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Characteristics of Explorative Formulations of Insulin Degludec and IDegAsp 50 in Healthy Japanese Subjects
|
Phase 1
|
Completed
|
|
NCT00393705
|
2006-10-01 |
Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019)
|
Phase 4
|
Completed
|
|
NCT01865305
|
2006-09-01 |
Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes
|
Phase 1
|
Completed
|
|
NCT00331604
|
2006-08-01 |
Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes
|
Phase 3
|
Terminated
|
|
NCT00353990
|
2006-08-01 |
Bioavailability of Insulin Administered in Duodenum
|
Phase 1/Phase 2
|
Completed
|
|
NCT01538511
|
2006-06-01 |
Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspart 30 in Healthy Volunteers
|
Phase 1
|
Completed
|
|
NCT00322257
|
2006-05-01 |
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
|
Phase 3
|
Terminated
|
|
NCT01536028
|
2006-04-01 |
Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT00313001
|
2006-04-01 |
Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.
|
Phase 3
|
Completed
|
|
NCT00318786
|
2006-04-01 |
Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT01530048
|
2006-03-01 |
Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL)
|
Phase 1
|
Completed
|
|
NCT00282451
|
2006-02-01 |
Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT00309244
|
2006-02-01 |
Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up
|
Phase 3
|
Completed
|
|
NCT00267683
|
2005-12-01 |
Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes
|
Phase 3
|
Terminated
|
|
NCT01486862
|
2005-10-01 |
Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs
|
Phase 4
|
Completed
|
|
NCT00202605
|
2005-09-01 |
Safety and Efficacy of SPD465 in Adults With ADHD
|
Phase 2
|
Completed
|
|
NCT00274274
|
2005-09-01 |
Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT00184561
|
2005-07-01 |
Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT00115973
|
2005-06-01 |
A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump
|
Phase 1
|
Completed
|
|
NCT00117780
|
2005-06-01 |
Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes
|
Phase 4
|
Completed
|
|
NCT01487811
|
2005-05-01 |
Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers
|
Phase 1
|
Completed
|
|
NCT00184613
|
2005-05-01 |
Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes
|
Phase 1
|
Completed
|
|
NCT00184574
|
2005-04-01 |
Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT00152022
|
2005-04-01 |
Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD.
|
Phase 3
|
Completed
|
|
NCT00120081
|
2005-04-01 |
Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection
|
Phase 1
|
Completed
|
|
NCT00504673
|
2005-04-01 |
Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT00152035
|
2005-03-01 |
Safety of SPD465 in Treating Adults With ADHD.
|
Phase 3
|
Completed
|
|
NCT00254085
|
2005-03-01 |
Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes.
|
Phase 4
|
Recruiting
|
|
NCT00106366
|
2005-03-01 |
Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT00470314
|
2005-01-01 |
Therapeutic Efficacy of L-Ornithine L-Aspartate Infusion in Patients With Acute Liver Failure
|
Phase 2
|
Active, Not Recruiting
|
|
NCT00097877
|
2005-01-01 |
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT00150579
|
2005-01-01 |
Efficacy and Safety of SPD465 in Adults With ADHD
|
Phase 3
|
Completed
|
|
NCT00494988
|
2004-12-01 |
Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin Aspart
|
Phase 4
|
Completed
|
|
NCT00184600
|
2004-11-01 |
Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT00101751
|
2004-10-01 |
INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study
|
Phase 4
|
Completed
|
|
NCT00097071
|
2004-10-01 |
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
|
Phase 3
|
Completed
|
|
NCT00461331
|
2004-10-01 |
Comparison of Insulins Aspart and Lispro in Insulin Pumps
|
Phase 4
|
Completed
|
|
NCT00097084
|
2004-09-01 |
Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT00184626
|
2004-09-01 |
Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.
|
Phase 4
|
Completed
|
|
NCT00095082
|
2004-09-01 |
Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes
|
Phase 3
|
Completed
|
|
NCT00097279
|
2004-08-01 |
Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT00747409
|
2004-07-01 |
Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes
|
Phase 4
|
Active, Not Recruiting
|
|
NCT00095446
|
2004-07-01 |
NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT00593255
|
2004-07-01 |
Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT00184665
|
2004-06-01 |
Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes
|
Phase 3
|
Completed
|
|
NCT00564668
|
2004-06-01 |
Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current Process to in Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT00624364
|
2004-05-01 |
Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT00500240
|
2004-04-01 |
Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)
|
Phase 3
|
Terminated
|
|
NCT00600366
|
2004-03-01 |
Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT00600626
|
2004-01-01 |
Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT00619697
|
2003-12-01 |
Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT00605020
|
2003-12-01 |
Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT00592969
|
2003-12-01 |
Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT01527656
|
2003-12-01 |
Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Subjects
|
Phase 1
|
Completed
|
|
NCT00595374
|
2003-12-01 |
Efficacy and Safety of Insulin Detemir in Type 1 Diabetes
|
Phase 3
|
Completed
|
|
NCT00605111
|
2003-12-01 |
Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT01527643
|
2003-11-01 |
Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Subjects
|
Phase 1
|
Completed
|
|
NCT00280046
|
2003-11-01 |
Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT00082407
|
2003-11-01 |
Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
|
Phase 3
|
Completed
|
|
NCT01620437
|
2003-11-01 |
Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Japanese Subjects
|
Phase 1
|
Completed
|
|
NCT00433368
|
2003-10-01 |
Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy
|
Phase 3
|
Completed
|
|
NCT00612599
|
2003-09-01 |
Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT00571935
|
2003-08-01 |
Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes
|
Phase 4
|
Completed
|
|
NCT00617565
|
2003-07-01 |
Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT00791895
|
2003-06-01 |
Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
|
Phase 4
|
Completed
|
|
NCT00604656
|
2003-05-01 |
Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 Diabetes
|
Phase 3
|
Completed
|
|
NCT00572806
|
2003-02-01 |
Initiation of Insulin Aspart in Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT00853008
|
2003-01-01 |
Treatment of High Risk Adult Acute Lymphoblastic Leukemia
|
Phase 4
|
Recruiting
|
|
NCT01486914
|
2003-01-01 |
Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process
|
Phase 1
|
Completed
|
|
NCT01527565
|
2003-01-01 |
Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Male Subjects
|
Phase 1
|
Completed
|
|
NCT00121966
|
2003-01-01 |
South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus
|
Phase 4
|
Completed
|
|
NCT01527552
|
2002-11-01 |
Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Male Subjects
|
Phase 1
|
Completed
|
|
NCT00598793
|
2002-11-01 |
Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy
|
Phase 4
|
Completed
|
|
NCT01527630
|
2002-11-01 |
Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Japanese Subjects
|
Phase 1
|
Completed
|
|
NCT00597233
|
2002-10-01 |
Human Insulin NPH and Insulin Aspart in Type 1 Diabetes
|
Phase 4
|
Completed
|
|
NCT00365170
|
2002-09-01 |
Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes
|
Phase 4
|
Completed
|
|
NCT01698697
|
2002-09-01 |
Comparison of Two Insulin Aspart Formulations in Healthy Volunteers
|
Phase 1
|
Completed
|
|
NCT00725036
|
2002-09-01 |
Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes
|
Phase 3
|
Completed
|
|
NCT01467401
|
2002-08-01 |
Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT00312156
|
2002-08-01 |
Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes
|
Phase 3
|
Completed
|
|
NCT01697631
|
2002-07-01 |
Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT01487798
|
2002-06-01 |
Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT00071448
|
2002-06-01 |
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
|
Phase 3
|
Completed
|
|
NCT01467141
|
2002-06-01 |
Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes
|
Phase 4
|
Completed
|
|
NCT01526980
|
2002-05-01 |
Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 Diabetes
|
Phase 2
|
Completed
|
|
NCT00312104
|
2002-04-01 |
Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes
|
Phase 3
|
Completed
|
|
NCT00513643
|
2002-04-01 |
Metabolic Effect of Insulin Aspart and Human Insulin in Different Doses
|
Phase 1
|
Completed
|
|
NCT01486940
|
2002-03-01 |
Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes
|
Phase 3
|
Completed
|
|
NCT01649570
|
2002-03-01 |
Safety and Efficacy of Insulin Aspart in Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT01486381
|
2002-03-01 |
Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes
|
Phase 3
|
Completed
|
|
NCT00676819
|
2002-01-01 |
Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT01527539
|
2001-11-01 |
Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT01697657
|
2001-09-01 |
Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes
|
Phase 3
|
Completed
|
|
NCT00072904
|
2001-06-01 |
Diabetes Therapy to Improve BMI and Lung Function in CF
|
Phase 3
|
Completed
|
|
NCT01526941
|
2001-05-01 |
Comparison of Single Dose and Steady State Pharmacodynamics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT01704378
|
2001-04-01 |
Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 Diabetes
|
Phase 4
|
Completed
|
|
NCT01620424
|
2001-02-01 |
Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 Diabetes
|
Phase 1
|
Completed
|
|
NCT01524809
|
2001-01-01 |
Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes
|
Phase 1
|
Completed
|
|
NCT01467375
|
2001-01-01 |
Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT01650129
|
2000-12-01 |
Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT00065130
|
2000-04-01 |
Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes
|
Phase 3
|
Completed
|
|
NCT01520818
|
2000-03-01 |
Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes
|
Phase 3
|
Completed
|
|
NCT01620333
|
2000-02-01 |
Pharmacokinetics of Biphasic Insulin Aspart 50 and 70 in Japanese Healthy Volunteers
|
Phase 1
|
Completed
|
|
NCT00832182
|
1999-12-01 |
Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes
|
Phase 3
|
Completed
|
|
NCT01523041
|
1999-11-01 |
Comparison of Two Formulations of Biphasic Insulin Aspart 70
|
Phase 1
|
Completed
|
|
NCT01520831
|
1999-04-01 |
Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy Subjects
|
Phase 1
|
Completed
|
|
NCT01520753
|
1999-03-01 |
Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT01467323
|
1998-04-01 |
Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes
|
Phase 3
|
Completed
|
|
NCT01707134
|
1997-09-01 |
Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes
|
Phase 3
|
Completed
|
|
NCT01697618
|
1997-04-01 |
Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes
|
Phase 2
|
Completed
|
|
NCT01707160
|
1995-11-01 |
Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 in Healthy Volunteers
|
Phase 1
|
Completed
|
|
NCT00410033
|
1989-12-01 |
Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin
|
Phase 3
|
Completed
|